Caledonia Investments (LSE:CLDN)
Caledonia's investment objective is to consistently achieve a long-term shareholder return in excess of the FTSE All-Share Total Return, while maintaining a progressive annual dividend.
About
Last updated 23-09-2019, 01:56:45pm BSTRelated Articles
-
Why I’d buy this investment trust ahead of Woodford Patient Capital
G A Chester explains why he'd avoid Woodford Patient Capital Trust plc (LON:WPCT) and buy this alternative instead. Read More »
-
Forget buy-to-let! I’d buy these 3 investment trusts for growth and income
Buy-to-let is a bother, but these investment trusts make investing for income and growth much easier, says Harvey Jones. Read More »
-
Investing for dividends? I’d consider these income champion investment trusts
These two investment trusts have lifted their dividends for 52 and 45 years in a row, respectively. Read on to find out who they... Read More »
-
Looking to invest £2,000? Here are two investment trusts I’d consider
I think investment trusts are a great way to start your portfolio. Here are two at the top of my list. Read More »
-
Top shares for November
We asked our writers to share their top stock picks for the month. Read More »
-
2 investment trusts I’d pick for a starter pension portfolio today
If I was starting out now building my pension portfolio, these are two investment trusts I'd seriously consider. Read More »
-
2 investment trusts I’d buy to beat the FTSE 100
These two neglected investment trusts look set to outperform the FTSE 100 (INDEXFTSE:UKX), says G A Chester. Read More »
-
Is this an unmissable opportunity to snap up these 2 global investment trusts?
These globally diversified investment trusts could add extra profits to your portfolio. Read More »
-
Looking for steady income? Consider these dividend investment trusts
These dividend investment trusts could offer safe, predictable, and growing income. Read More »
-
This FTSE 100-beating investment trust could be a better buy than GlaxoSmithKline plc
Roland Head suggests a long-term alternative to FTSE 100 (INDEXFTSE:UKX) pharma giant GlaxoSmithKline plc (LON:GSK). Read More »
